Tag Archives: Ingrown toenails

Rubinstein-Taybi Syndrome: A case report

by Taren Cardona, BS1, Al Kline, DPM2

The Foot & Ankle Journal 1 (7): 3

Rubinstein-Taybi Syndrome (RSTS) is a rare genetic disorder. Individuals are characterized by broad halluces and thumbs, hyper-extensible joints and other classic features. The broad hallux often leads to complications such as ingrown toe nails. The syndrome is extremely rare and this appears to be the first reported case in the podiatric literature.

Key words: Rubinstein-Taybi Syndrome, RSTS, Onychocryptosis

This is an Open Access article distributed under the terms of the Creative Commons Attribution License.  It permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ©The Foot & Ankle Journal (www.faoj.org)

Accepted: May 2008
Published: July 2008

ISSN 1941-6806
doi: 10.3827/faoj.2008.0107.0003

Rubinstein-Taybi Syndrome (RSTS) was first described in 1957 as a single case report, and then in 1963 Rubinstein and Taybi described a syndrome of broad fingers and great toes, facial abnormalities and mental retardation as observed in seven children. [7] Clinical characteristics of these individuals include short stature, beaked nose, anti-mongoloid slant of eyes, heavy/high arched eyebrows, microcephaly, broad thumbs and hallux which are often angulated, hyper-extensive joints, small tilted pelvis, hypertrichosis, and undescended testes. [2]

Current literature reports that 100% of all RSTS patients present with broad halluces. The condition is extremely rare (1:300,000 up to 1:1,000,000). [2] The podiatric and orthopedic community should be aware of the syndrome and its associated complications. The purpose of this report is to provide information on RSTS and the associated complications. In this paper we report a case encountered on referral for ingrown hallux nail.

Case Report

A 12 year old male presents to the office setting with a painful ingrown toe nail with a broad hallux and nail plate. The patient’s medical history includes Rubinstein-Taybi Syndrome (RSTS), a recent surgery on bilateral polluces, previous foot surgery and a heart condition at birth. The patient appeared small for his stated age and had striking facial features. (Figs. 1) He was very pleasant on examination and mentally retarded.


Figures 1  The facial features of Rubinstein-Taybi Syndrome.  These include anti-mongoloid slant of eyes, heavy eye brows, low set ears and beaked nose.

Clinically, the hallux was broad bilaterally and a skin cleft was noted along the plantar first interspace. (Fig. 2) The patient’s hallux nail was incurvated with mild hypertrophy to the ungula labia of the nail folds. (Fig. 3) There is positive pain on palpation of the area as evident from his withdraw response. Hyperextensible joints were noted. The patient’s thumbs were broad with recently corrected radial angulation. (Figs. 4)

Figure 2  There is a plantar cleft to the plantar first interspace, hyper-extensible joint and broad hallux.

Figure 3  The hallux nail plate is  broad with inflammation and pain to the nail borders and ungula nail folds.


Figures 4  The thumbs have been corrected from ulnar deviation.  The broadness of the thumb is still evident. 

Since the hallux nail was painful, we elected to perform a modified Winograd procedure as an outpatient procedure in a surgical center. Anesthesia administered nitrous oxide via mask and local anesthetic with tourniquet was utilized.

Patient tolerated the procedure well with no complication.


Although this was a simple case of onychocryptosis, we found this presenting case worthy of documentation and literature review. It appears there is very little documented evidence of this syndrome in the podiatric and orthopaedic literature.

RSTS occurs when a mutation of the CREB-binding protein (CREBBP) causes a genetic defect. Although several molecular and genetic investigations have been undertaken, the syndrome has not been definitively characterized by a single deletion or translocation. One of the more common findings is a mutation of the EP300 gene and that a microdeletion is most likely the problem. Petrij, et al., reported all patients with RSTS studied demonstrated a deletion at 16p13.3 with is the region coding for CREBBP. [5] CREBBP is a transcription coactivator and functions as a potent histone acetyltransferase, both of which are essential to normal development. [6] Petriji, et al., proposed that the loss of one functional allele for the CREBBP is responsible for the propensity of RSTS patients to form neoplams and keloids.

In animal models, the mice with truncated Crb protein demonstrated clinical features of RSTS observed in humans including growth retardation, retarded osseous maturation, hypoplastic maxilla with narrow palate, cardiac and skeletal abnormalities. [4]

Clinically there is a variety of symptoms observed in this syndrome. All patients (100%) are observed to have a broad hallux and hypoplastic maxilla with narrow palate. Commonly observed features include: prominent beaked nose (90%), antimongoloid palpebral fissures (88%), low-set/malformed ears (84%), strabismus (69%), broad thumbs with radial angulation (87%), broad fingers (87%), mental retardation with IQ of less than 50 found (> 50%), speech difficulties (90%), hypotonia (67%), hirsutism (75%), capillary nevus of the forehead or the nape (>50%), and cryptorchidism (78% of males). [3]

Also described are large anterior fontanelle (41%), microcephaly (35%), Small mouth, persistent fetal finger pads (31%), duplicated longitudinal bracketed epiphysis (kissing delta phalanx), syndactyly, polydactyly, ulnar deviation of the thumb, congenital or juvenile glaucoma, ptosis, growth retardation, echolalia, retarded osseous maturation (49%), vertebral and sternal abnormalities, patellar dislocation, patellofemoral instability, fourth cuneiform bones, joint hyper mobility, keloid formation (4.87%), cardiac anomalies (32.6%), and ECG abnormalities (30%). [3]

Our patient presented with the characteristic broad hallux bilaterally, small jaw and beaked nose, anti Mongoloid eye slant, low set ears, surgically corrected thumbs, short and stubby fingers, mental retardation, echolalia and speech difficulty, hyperextensible joints, and keloid formation. The finding of chronic ingrown nails is most likely a consequence of a broad hallux. Baran described a condition of “Congenital malalignment of the great toenails” and proposed that a nail plate which is not parallel with the distal phalanx is the cause of recurrent ingrown nails. [1]

The hypermobility of the first metatarsophalangeal joint with broad hallux may explain the unusual skin cleft to the plantar first interspace of the foot.

Another important aspect of RSTS is the proclivity of patients to be sensitive to succinylcholine. Cardiac arrhythmia can develop with administration, so the clinician must be aware of the condition and possible adverse reactions. It is advised that patients be treated with sedation and local anesthetic when applicable rather than general anesthesia as intubation may necessitate muscle cell depolarization for insertion. Additionally these patients are at risk for aspiration during anesthesia due to laryngeal wall collapsibility, abnormal pulmonary lobulation, congenital tracheal stenosis, excess mucous secretion and gastro esophageal reflux all of which are common. [3]

In conclusion, RSTS is a rare genetic condition that invariably involves the lower extremity-in particular the halluces. We present this case report to inform the podiatric community of this condition and document a rare syndrome.


1. Baran R, Bureau H, Sayag J. Congenital malalignment of the big toenail. Clin Exp Dermatol. 4:359–360, 1979.
2. Baxter, Garry and Lorrie. Rubinstein-Taybi Parent Group. First Printing, April 90 Second Printing – Updated – February 92 Third Printing, [Online].
3.Mijuskovic, Z. Rubinstein-Taybi Syndrome Last Updated: Sep 20, 2006. e-medicine.Author: Zeljko P Mijuskovic, MD, Coauthor(s): Djordjije Karadaglic, MD, DSc, Ljubomir Stojanov, MD, PhD, [Online].
4. Oike, Y.; Hata, A.; Mamiya, T.; Kaname, T.; Noda, Y.; Suzuki, M.; Yasue, H.; Nabeshima, T.; Araki, K.; Yamamura, K. : Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum. Molec. Genet. 8: 387-396, 1999.
5. Petrij, F.; Giles, R. H.; Dauwerse, H. G.; Saris, J. J.; Hennekam, R. C. M.; Masuno, M.; Tommerup, N.; van Ommen, G.-J. B.; Goodman, R. H.; Peters, D. J. M.; Breuning, M. H. : Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376: 348-351, 1995. PubMed ID : 7630403.
6. Roelfsema, J. H.; White, S. J.; Ariyurek, Y.; Bartholdi, D.; Niedrist, D.; Papadia, F.; Bacino, C. A.; den Dunnen, J. T.; van Ommen, G.-J. B.; Breuning, M. H.; Hennekam, R. C.; Peters, D. J. M. : Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am. J. Hum. Genet. 76: 572-580, 2005.
7. Rubinstein, J. H.; Taybi, H. : Broad thumbs and toes and facial abnormalities. Am. J. Dis. Child. 105: 588-608, 1963.

Address correspondence to: Al Kline, DPM
3130 South Alameda, Corpus Christi, Texas 78404.
Email: Al@Kline.net

1 Submitted during clinical clerkship in May 2008, Corpus Christi, Texas 78404. Fourth year podiatry student, Barry University School of Podiatric Medicine.

2 Adjunct Clinical Faculty, Barry University School of Podiatric Medicine. Private practice, Chief of Podiatry, Doctors Regional Medical Center. Corpus Christi, Texas, 78411.

© The Foot & Ankle Journal, 2008

Onychocryptosis: A Simple Classification System

by Al Kline, DPM1

The Foot & Ankle Journal 1 (5): 6

The author presents a simple classification system for documenting onychocryptosis. The classification system describes the different stages of an ingrown toe nail and describes the associated treatment algorithm for each stage. The causes of onychocryptosis and the considerations for surgery are discussed. The author uses this classification system in every day practice for concise, office documentation.

Key words: Onychocryptosis, ingrown toenail, nail infection

This is an Open Access article distributed under the terms of the Creative Commons Attribution License.  It permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ©The Foot & Ankle Journal (www.faoj.org 

Accepted: April 2008
Published: May 1, 2008

ISSN 1941-6806
doi: 10.3827/faoj.2008.0105.0006

There have been a number of articles written on the treatment of onychocryptosis or ingrown toe nails.[1-23] It is well known that matrixectomies performed in the presence of nail border onycholysis and gross infection can lead to recurrence and poor cosmetic results. In this paper, it is the authors attempt to introduce a simple classification system to determine at what point the matrixectomy should be performed. The classification system also gives the practitioner a tool for documenting the severity of the ingrown toe nail at initial presentation.

Nail procedures can be divided into two variable types 1) temporary procedures for removal of granulation tissue, offending nail, and/or skin of the offending nail border and 2) permanent destruction of a part or whole region of the nail matrix. Chemical cauterization using phenol is probably the most common permanent, partial or complete nail matrixectomy performed today. In recent years, state-of-the-art procedures such as laser and radio ablation have been described. As early as 1938, Vernon [1] described using electrocautery to destroy the nail matrix. Thermocautery, electroburring, cryotherapy with liquid nitrogen, aluminum nail splints and Teflon bracing have also been described in the treatment of onychocryptosis.

The causes of onychocryptosis are multifactorial. It seems to affect individuals of varying ages and has no predilection to gender. Trauma appears to play a major role. This can be in the form of improper pedicures, poorly fitting shoes, cutting the nail too close to the nail folds and general trauma such as stubbing the toe or having the toe injured in sport activities. Improper cutting of the nail borders can lead to a spiculated nail. This is where a portion of the nail deep to the nail fold is imbedded into the nail groove. The nail continues to grow deep in the groove and can penetrate the distal pulp of the toe. Onychocryptosis can also occur in infants and young children. Treatment before the age of 1 year should involve symptomatic relief by simple debridement. Removal of the nail border will usually resolve the local infection. Once the infant is ambulatory or after 1 year of age, a chemical as well as sharp surgical partial matrixectomy can successfully be performed.

Considerations in Nail Surgery

Since nail border onychocryptosis is one of the most common podiatric conditions the physician will see in the office or clinic, a good understanding of technique is crucial to a good surgical outcome. Efforts should be made to keep the procedure simple to get the best cosmetic result.

Considerations for getting the best surgical result include 1) removal of offending nail in mild cases, 2) removal of proud flesh or granular tissue from the nail border in more severe cases, 3) determination of onycholysis due to local infection, 4) overall condition and health of the nail plate, 5) prevention of traumatic onycholysis of healthy nail during the procedure and 6) proper post operative care and treatment. Other considerations of treatment should include the exclusion of nail border and bone pathology. Amelanotic melanoma, squamous cell carcinoma and other tissue pathologies have been described with associated “ingrown toenails”. Bone pathology such as osteochondromas and direct extension osteomyelitis should also be ruled out.

It is important to visually and manually inspect the nail border involved. Many times, the treating physician will see varying degrees of ingrown toe nail infection. It is important to determine the extent of the infection. Is this a mild infection or is it severe? Is there granulation tissue causing the nail to loosen or lift? Is a nail spicule present or abscess? Has there been history of infection and onychocryptosis to this nail border before? These questions are important to answer before performing the nail procedure.

The premise for a classification system is to address these questions and give the patient the best cosmetic and surgical result. It also gives the treating physician a plan of action that can be discussed with the patient in cases of more severe onychocryptosis that has compromised nail viability. It is well known that trying to perform a matrixectomy in the presence of onycholysis will lead to nail disfigurement and poor cosmetic results. An argument can also be made that in severe cases of infection, there is a risk of periostitis and bone infection that in most cases should be addressed before attempting a chemical or surgical matrixectomy.

The risks of untreated onychocryptosis have been well documented. Simple paronychia or inflammation of the nail border, can lead to cellulitis and even periostitis or osteomyelitis of bone. [21] Local abscesses such as a distal pulp abscess of the toe is common when the untreated nail spicule is left to penetrate the underlying distal nail groove. In severe cases of abscess and infection, simple partial and even total nail avulsions are indicated with resection of abnormal granulation tissue. Radiographs are recommended to rule out any bone involvement such as periosteal changes or osteomyelitis.

Antibiotic therapy is indicated and the patient may return at a future time for a second stage matrixectomy of the nail border once the infection and inflammation has resolved.

A Simple Classification for Treatment

The idea for a simple classification is based primarily on the severity and presentation of initial clinical findings. Treatment protocol is primarily based on the presence of nail onycholysis or loosening of the offending nail border or nail plate. This is the most important consideration in order to attain a good cosmetic result after matrixectomy. A simple curette or probe can be used to determine the viability of the nail border after removal of the offending nail border. The author has found the use of the #62 beaver blade to be the best surgical tool to provide the least amount of trauma and risk or nail separation during nail border removal. Matrixectomy does not have to be confined strictly to chemical cauterization. The classification is useful to quickly document the severity of the condition.

Stage 1

This is the mildest form of presentable onychocryptosis. (Fig. 1)

Figure 1 In stage 1 onychocryptosis there is a locally infected region of the nail with good nail attachment.  No onycholysis of the nail border is appreciated.  The hallmark of stage 1 is local irritation of the nail fold without gross infection or granulation tissue.  This can be with or without a history of onychocryptosis.

The nail border is mildly irritated or inflamed with no real sign of infection. There is no sign of drainage or pus. There is no sign of nail onycholysis. There may or may not be a history of previous onychocryptosis to the affected nail border. The hallmark of this stage is local irritation of the nail fold without gross infection or granulation tissue. This can be with or without a history of onychocryptosis. The patient who presents with this condition typically notices the irritation. The patient may self treat the ingrown toe nail or see the practitioner promptly. Treatment involves simple debridement of the offending nail border. The procedure is usually performed without the need for local anesthetic. The patient may also opt to undergo a matrixectomy if the condition is recurrent. Antibiotics are not required after treatment. Suppan was one of the first to identify that the phenol technique is most effective where there is no gross hypertrophy of the unguilabia. [10]

Stage 2

In stage 2 onychocryptosis, the nail border is more inflamed usually with the appearance of drainage or pus. (Fig. 2)

Figure 2 In stage 2 onychocryptosis there is increased local infection of the nail border with good nail attachment.  No onycholysis of the nail border is appreciated.  The hallmark of stage 2 is infection of the nail border with pus and/or granulation tissue without a history of onychocryptosis.

The hallmark of this stage is infection of the nail border with pus and/or granulation tissue without a history of onychocryptosis. There may or may not be pus and/or granulation tissue. These findings differ from stage one where there is no signs of gross infection, granulation or drainage. Treatment involves removing the offending nail border surgically under local anesthesia. Granulation tissue can also be surgically excised with or without the application of silver nitrate or by Winograd resection. Sometimes, surgical removal can be attempted without anesthesia by more aggressive debridement of the nail border, but it is not recommended.

The patient may or may not opt to undergo a matrixectomy. If matrixectomy is performed, the practitioner may choose to place the patient on oral antibiotics, but it is usually not required.

Stage 3

This stage only differs slightly from stage 2. The hallmark of this stage is infection of the nail border with a history of more than one episode of onychocryptosis to the affected nail border. (Fig. 3)

Figure 3 In stage 3 onychocryptosis there is local granulation and/or pus of the nail border with good nail attachment.  No onycholysis of the nail border is appreciated.  Stage 3 differs from stage 2 by the presence of recurrent episodes of onychocryptosis to the nail border.    The hallmark of stage 3 is infection of the nail border with a history of more than one episode of onychocryptosis to the affected nail border.

As in stage 2, the patient will usually present with granulation tissue and/or drainage to the nail fold. It is important to remember that stage 2 and stage 3 only differ by history. If this is a first episode of onychocryptosis, it is stage 2. If this is a second episode, then it is stage 3. Treatment involves surgical removal of the offending nail border and resection of granulation tissue under local anesthesia. Matrixectomy is recommended due to the history of recurrence.

The procedure of choice is the Winograd procedure to remove hypertrophic granulation and provide a chemical matrixectomy. Antibiotics may or may not be used after treatment.

Another important consideration of stage 3 onychocryptosis is the presence of onycholysis or loosening of the nail plate or border. A simple curette or probe can be used to identify signs of onycholysis. If there are signs of nail plate or nail border loosening, the nail is automatically classified as a stage 4 onychocryptosis.

Stage 4

The hallmark of this stage includes infective onychocryptosis with partial onycholysis of a single nail border. (Fig. 4)

Figure 4 In stage 4 onychocryptosis there is noticeable onycholysis of the nail border.  Matrixectomy of the nail border is not recommended.   The hallmark of stage 4 is infective onychocryptosis with partial onycholysis of a single nail border.

Interestingly, a history of previous onychocryptosis or ingrown toe nail is not a consideration in this stage. The patient typically presents with increased granulation tissue, drainage and infection to one nail border. Paronychia can present with or without granulation tissue. However, the formation of excessive granulation tissue to the nail border is the likely cause of nail border onycholysis. Chemical cauterization in this stage is not recommended. Surgical chemical matrixectomy should be avoided. It is the author’s preference to avoid any type of cauterization that will disturb the nail matrix. The patient may return for a secondary staged procedure to undergo a more permanent nail matrixectomy once the infected region is healed.

The primary concern in this stage is the removal of the offending nail and granulation tissue allowing for resolution of infection without disturbing the healthy, exposed germinal matrix. Attempts at chemical cauterization in this stage will likely lead to destruction of health nail matrix and cause a poor cosmetic result.

Typically, the surgeon can wait 6 to 8 weeks before attempting a more permanent nail procedure. The patient can also return for treatment if, during nail regrowth, there are signs of recurrent infection. In this stage, determining adherence of the nail bed is crucial in determining if a matrixectomy should be performed. It is also prudent to take radiographs of the toe in this stage if the duration of infection is over 6 months. Long standing onychocryptosis has been shown to cause direct extension osteomyelitis of the distal phalanx. [23]

If there is any question of the nail’s integrity, a nail matrixectomy can be performed at a later time. Treatment of the underlying infection should be a primary concern and addressed with surgery and oral antibiotics.

Stage 5

The hallmark of this final stage includes infective onychocryptosis with partial or complete onycholysis of the nail plate and/or nail border involving both nail borders. (Fig. 5)

Figure 5 In stage 5 onychocryptosis there is noticeable onycholysis of both nail borders and even the nail plate.  Matrixectomy is not recommended.   The hallmark of stage 5 is infective onychocryptosis with partial or complete onycholysis of the nail plate and/or nail involving both nail borders.

This is of course the most severe type of onychocryptosis. Complete avulsion of the nail plate is recommended in order to resolve soft tissue infection. Removal and resection of granulation tissue by sharp dissection is recommended, ensuring not to disturb the germinal matrix. Radiographs are also indicated to rule out osteomyelitis in cases of chronic onychocryptosis. If there is suspicion based on history and duration of infection (i.e. ingrown toenail for 6 months to a year or more), MRI is indicated. Antibiotic treatment with daily soaks in Epsom salt is recommended. Any form of matrixectomy is strongly discouraged until the infection is resolved and a new nail is adherent to the nail bed without onycholysis. If osteomyelitis is present, intravenous antibiotics for 6 weeks are indicated with a Ceretec (white blood-cell labeled) bone scan after treatment. If osteomyelitis is aggressive with lysis of bone, surgical debridement is indicated.


In 2002, Mozena attempted classifying ingrown hallux nails and proposing a treatment algorithm based on measuring the ungual labia nail fold. [21] In 25 infected nails and 100 normal nails, the author found that the normal depth of the ungual labia fold was between 0.5 to 3.0 mm (average 1.8 mm). Staging was based on nail fold depth and extent of infection and granulation tissue. (Stages I, IIa, IIb, III) As recent as 2007, Martinez-Nova, et al, also proposed a “new classification and treatment plan” for ingrown toenails.22 (Stages I, IIa, IIb, III, IV)

This classification used both clinical symptoms and presentation with nail fold measurements with staging similar to that proposed by Mozena. Both authors used the 3.0 mm nail fold depth as a measurement to when it is best to resect or reduce the ungual labial fold. Both authors also suggest that matrixectomy is indicated in the most severe stages. Unfortunately, there is no mention of what to do in cases when onycholysis of the nail may expose normal nail matrix to phenol. Our staging procedure recommends not using phenol when nail borders show onycholysis. Additionally, both of these proposed classifications do not address the risk of nail pathologies and osteomyelitis associated with chronic onychocryptosis in the algorithms.

Staging the severity of onychocryptosis has its advantages. I believe this visual classification of identifying infection and staging the toe infection helps in the documentation process where a simple algorithm can be formulated to best treat the condition. (Table 1)

Table 1 Treatment algorithm.

Certainly, nail dystrophy or other nail changes could alter the use of the classification. If the nail is thickened or secondarily infected with fungus, the predictability of the matrixectomy procedure will diminish. Subungual mycosis will cause structural onycholysis of the underlying nail plate not involved with the ingrown toenail. In cases of severe, chronic mycosis, onychogryphosis, onychauxis or severe pincer nail formation, complete permanent avulsion of the nail plate is recommended.

Of course, if there is traumatic injury to the nail, nail avulsion and proper drainage of subungual hematoma or repair of the nail bed and/or matrix is recommended.

If there is no sign of onycholysis or gross onychomycosis of the nail border and the condition is recurrent, matrixectomy using chemical phenol cauterization is the author’s procedure of choice. Proper technique is crucial to a good surgical outcome. This includes proper hemostasis using a toe tourniquet.

This allows for proper cauterization of the nail matrix using pure phenol without dilutional contamination which will decrease the efficacy of the phenol. The author also uses a small #62 beaver blade to perform the matrixectomy. It is crucial to not disturb the normal nail matrix during this most important step. Larger instruments such as elevators or an English anvil nail splitter is discouraged.

These instruments are too large for proper dissection of a small nail border. Once the nail is cut back to the matrix with the #62 blade, a small, straight hemostat is used to remove the nail border. Proper post operative care should include daily soaking with a hypertonic solution such as salt water or Epsom salt soaks. Rarely are antibiotics required after chemical cauterization.

Although classification systems in general are purely academic, the attempt to classifying the severity of onychocryptosis may help in constructing a treatment plan of when it is safe to perform a chemical cauterization and get the best cosmetic results. The classification system can be used as a guideline to making these decisions. Certainly, variations of treatment will exist. Sometimes, even in Stage 1 and 2 onychocryptosis, the decision to perform a matrixectomy is acceptable if it is thought that there may be a risk of recurrence or if the patient desires it. Options for permanent versus temporary removal of the nail border are always an option except in stage 4 or 5. In stages 4 and 5, the primary concern should be to resolve the infection and rule out any other conditions, such as osteomyelitis in chronic cases of onychocryptosis. Matrixectomies can always be performed at a later time when the risk of the infection will not interfere with the cosmetic result. Also, performing a chemical, cold-steel, or other form of cauterization in stages 4 or 5 may cause potential risk of direct extension osteomyelitis.

The variability of procedures is primarily the choice of the treating physician. There are obvious situations when leaving the matrix alone is desirable and the patient can return for future matrixectomy to prevent recurrence.

The correction of ingrown toenails should be performed in order to remove an offending nail border, drain pus or remove granulation tissue and perform a permanent procedure to prevent future recurrence. Careful attention to the structure and viability of the nail plate is an important consideration to choosing these treatment options. Performing a permanent matrixectomy in the absence of onycholysis and gross infection will assure the patient the best cosmetic result.


1. Vernon, S. Ingrown Toenail, Operation by Electrocautery, Am J Surg., 42:396-397, 1938
2. Winograd, A.M. A Modification in the Technique of Operation for Ingrown Toenail JAMA 92:229-230, 1929
3. Winograd, A.M. Results in Operation for ingrown Toenail, Illinoid MJ 70:197-198, 1936.
4. Frost, L. Root Resection for Incurvated Nail J Nat Assoc of Chir 40(3): 19-27, 1950.
5. Frost, L. Atraumatic Nail Avulsion with a Novel Ungual Elevator JAPA Vol 48, No. 2 , Feb, 1958.
6. Gilles, G.A. et al Periostitis associated with Phenol Matricectomies JAPMA, 76 (8), Aug 1986.
7. Kaplan, E.G. Elimination of Onychauxis by Surgery JAPA 50(2), Feb 1960.
8. Gottlieb, M.M. The Permanent Removal of Nails by Evulsion and Chemical Cauterization, Current Chiropody, August , 1953.
9. Boll, Otto F. Surgical Correction of Ingrowing Nails, J Nat Assoc of Chir; Presented before the March 1945 meeting of the American society of Foot Surgeons.
10. Suppan RJ, Ritchlin JD: A Non Debilitating Surgical Procedure for “Ingrown toenail”. J Am Podiatry Assoc 52 (11) :900,1962.
11. Sadhu, S., Bhat , K. Ingrown Toenail: Results of Surgical Matrixectomy JK Science 6(3), July-Sept ,2004.
12. Emmert, C. Operations for Ingrown Nail, Arch. F. Klin. Arch. 11:268-277,1869.
13. Michaelis, H.J. Ingrown Nails J.D. Chir. U. Augenh. 14:234-255, 1830.
14. Heifetz, C.F. Operative management of Ingrown Toenail, J Missouri M.A. 213-216, April 1945.
15. Clarke, B.G. Dillanger, K.A. Surgical Treatment of Ingrown Nail, Surgery, 919-924, June, 1947.
16. Wilson, T.E. The Treatment of Ingrowing Toenails, MJ Australia, 2:33, July, 1944.
17. Nuttall, H.C.W. Ingrowing Toenail, Lancet 2:100, July 1941.
18. Keyes, E.L. The Surgical Treatment of Ingrown Toenails JAMA 102:1458-1460, 1934.
19. Barlett, R.W. A Conservative Operation for the Cure of So-called Ingrown Toenail JAMA 1257-1258, April , 1937.
20. Linch, A.O. Treatment of Ingrown Toenails, The Southern Surgeon, 173-174, 1939.
21. Cox, HA. Direct Extension Osteomyelitis Secondary to Chronic Onychocryptosis. Three case reports JAPMA 85 (6), 321-24, 1995.
22. Mozena, J.D. The Mozena Classification System and Treatment Algorithm for Ingrown Hallux Nails. JAPMA 92 (3), 131-35, 2002.
23. Martinez-Nova, A. et al. A New Onychocryptosis Classification and Treatment Plan. JAPMA 97 (5), 389-93, 2007.

Address correspondence to: Dr. Al Kline, DPM, 3130 South Alameda, Corpus Christi, Texas 78404. E-mail: al@kline.net

1 Adjunct Clinical Faculty, Barry University School of Podiatric Medicine. Private practice, Chief of Podiatry, Doctors Regional Medical Center. Corpus Christi, Texas, 78411.

© The Foot & Ankle Journal, 2008